Literature DB >> 16219483

Melatonin.

Rüdiger Hardeland1, S R Pandi-Perumal, Daniel P Cardinali.   

Abstract

Melatonin, originally discovered as a hormone of the pineal gland, is produced by bacteria, protozoa, plants, fungi, invertebrates, and various extrapineal sites of vertebrates, including gut, skin, Harderian gland, and leukocytes. Biosynthetic pathways seem to be identical. Actions are pleiotropic, mediated by membrane and nuclear receptors, other binding sites or chemical interactions. Melatonin regulates the sleep/wake cycle, other circadian and seasonal rhythms, and acts as an immunostimulator and cytoprotective agent. Circulating melatonin is mostly 6-hydroxylated by hepatic P450 monooxygenases and excreted as 6-sulfatoxymelatonin. Pyrrole-ring cleavage is of higher importance in other tissues, especially the brain. The product, N1-acetyl-N2-formyl-5-methoxykynuramine, is formed by enzymatic, pseudoenzymatic, photocatalytic, and numerous free-radical reactions. Additional metabolites result from hydroxylation and nitrosation. The secondary metabolite, N1-acetyl-5-methoxykynuramine, supports mitochondrial function and downregulates cyclooxygenase 2. Antioxidative protection, safeguarding of mitochondrial electron flux, and in particular, neuroprotection, have been demonstrated in many experimental systems. Findings are encouraging to use melatonin as a sleep promoter and in preventing progression of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219483     DOI: 10.1016/j.biocel.2005.08.020

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  67 in total

Review 1.  Urban environment and cancer in wildlife: available evidence and future research avenues.

Authors:  Tuul Sepp; Beata Ujvari; Paul W Ewald; Frédéric Thomas; Mathieu Giraudeau
Journal:  Proc Biol Sci       Date:  2019-01-16       Impact factor: 5.349

2.  Agomelatine protects against myocardial ischemia reperfusion injury by inhibiting mitochondrial permeability transition pore opening.

Authors:  Pengyu Jia; Chunting Liu; Nan Wu; Dalin Jia; Yingxian Sun
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

Review 3.  Utilizing melatonin to combat bacterial infections and septic injury.

Authors:  Wei Hu; Chao Deng; Zhiqiang Ma; Dongjin Wang; Chongxi Fan; Tian Li; Shouyin Di; Bing Gong; Russel J Reiter; Yang Yang
Journal:  Br J Pharmacol       Date:  2017-03-21       Impact factor: 8.739

4.  Dual effects of melatonin on oxidative stress after surgical brain injury in rats.

Authors:  Steve Lee; Vikram Jadhav; Robert E Ayer; Hugo Rojas; Amy Hyong; Tim Lekic; Jiping Tang; John H Zhang
Journal:  J Pineal Res       Date:  2008-06-18       Impact factor: 13.007

5.  The Effect of Circadian Melatonin Levels on Inflammation and Neurocognitive Functions Following Coronary Bypass Surgery.

Authors:  Sırma Geyik; Remzi Yiğiter; Aylin Akçalı; Hayati Deniz; Abidin Murat Geyik; Mehmet Ali Elçi; Erhan Hafız
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-05-25       Impact factor: 1.520

6.  Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves' orbitopathy (GO): a new frontier for GO treatment?

Authors:  G Rotondo Dottore; I Ionni; F Menconi; G Casini; S Sellari-Franceschini; M Nardi; P Vitti; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2017-06-27       Impact factor: 4.256

7.  Melatonin attenuates hLRRK2-induced long-term memory deficit in a Drosophila model of Parkinson's disease.

Authors:  Dongzhi Ran; Baogang Xie; Zongjie Gan; Xicui Sun; Huaiyu Gu; Junqing Yang
Journal:  Biomed Rep       Date:  2018-07-05

8.  Cryo-EM structure of the human MT1-Gi signaling complex.

Authors:  Hiroyuki H Okamoto; Hirotake Miyauchi; Asuka Inoue; Francesco Raimondi; Hirokazu Tsujimoto; Tsukasa Kusakizako; Wataru Shihoya; Keitaro Yamashita; Ryoji Suno; Norimichi Nomura; Takuya Kobayashi; So Iwata; Tomohiro Nishizawa; Osamu Nureki
Journal:  Nat Struct Mol Biol       Date:  2021-08-05       Impact factor: 15.369

9.  Melatonin and its metabolites accumulate in the human epidermis in vivo and inhibit proliferation and tyrosinase activity in epidermal melanocytes in vitro.

Authors:  Tae-Kang Kim; Zongtao Lin; William J Tidwell; We Li; Andrzej T Slominski
Journal:  Mol Cell Endocrinol       Date:  2014-08-27       Impact factor: 4.102

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.